Stock Movers

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Stellantis will take roughly €22 billion ($26 billion) in charges linked to a sweeping overhaul of its operations as high costs and muted electric-vehicle sales force the automaker to adjust its strategy. Stellantis shares fell as much as 14% in Milan, with the announced charges exceeding analyst projections.
-Societe Generale's stock declined after it reported fourth-quarter results for its trading units that missed estimates. Revenue from buying and selling fixed income securities and currencies fell 13% in the period from a year earlier, while equities trading fell 5.3%, it said in a statement on Friday. Analysts had anticipated growth for both units. Shares in the lender dropped as much 3.9% in early Paris trading.
- Banco Sabadell Chief Executive Officer César González-Bueno is leaving in a surprise move just a few months after he led the lender’s successful defense against a hostile bid from rival BBVA. Shares in Sabadell dropped as much as 6.5% in early Madrid trading.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Stellantis will take roughly €22 billion ($26 billion) in charges linked to a sweeping overhaul of its operations as high costs and muted electric-vehicle sales force the automaker to adjust its strategy. Stellantis shares fell as much as 14% in Milan, with the announced charges exceeding analyst projections.
- Kongsberg shares soar as much as 17%, the most on record, after the Norwegian defense firm posted results that Morgan Stanley says delivered a strong end to the year, with all divisions recording double-digit growth in the fourth quarter.
- Orsted shares rise 4.5% after the Danish wind company reaffirmed its Ebitda excluding items forecast for 2026. Analysts from Jefferies and Morgan Stanley flag reassurance on the construction timelines of US projects.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Amazon (AMZN) shares dipped in afterhours trading following earnings. The company said it plans to spend $200 billion this year on data centers, chips and other equipment, worrying investors the company’s colossal bet on artificial intelligence will pinch profits while it waits for investments to pay off.
- Strategy shares (MSTR) fell in extended hours trading as Bitcoin's plunge below $65,000 is intensifying the crisis rocking the digital-asset complex. In an earnings announcement Thursday, the Bitcoin-hoarding company confirmed a net loss of $12.4 billion for the fourth quarter, driven by the mark-to-market decline in its vast holdings. That pain deepened this week, as fresh market turmoil pushed the firm’s Bitcoin stash below its cumulative cost basis for the first time since 2023 — and erased the token’s post-election gains.
- Ares Management Corp. (ARES) shares ended the day lower in a broad selloff among alternative asset managers over fears of AI disruption, even as the firm reported that it ended the fourth quarter with record assets. Alternative investment firms are exposed to companies that make financial and legal software products at risk of being rendered obsolete by artificial intelligence. In a nod to those concerns, Ares noted in its earnings statement that exposure to the software industry — where stocks have plunged in recent days — represents 6% of total assets, and less than 9% of private credit.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
-Strategy (MSTR) shares sink as Bitcoin tumbled below $70,000 as the unwinding of leveraged bets and broader market turbulence deepened a selloff that has wiped out all of the gains since President Donald Trump’s election set off a speculative rush into cryptocurrencies. The token fell as much as 10% Thursday to $65,344, the lowest since October 2024. The rout has erased nearly half of Bitcoin’s value since it reached a record four months ago and has spread to other tokens, related ETFs and companies like Strategy Inc. that hold vast sums of coins.

-Alphabet (GOOGL) shares drop as the company is poised to spend more in 2026 than it has invested in the past three years combined to finance an unprecedented expansion of data centers critical to its artificial intelligence ambitions. Google’s parent company said capital expenditures will reach as much as $185 billion this year, far exceeding the $119.5 billion that analysts had expected and double what it spent last year.

-Estee Lauder (EL) shares fall after its outlook boost failed to reassure investors about the pace of the cosmetics conglomerate’s turnaround. The owner of the Jo Malone and Le Labo brands expects adjusted earnings per share in the range of $2.05 to $2.25 this fiscal year, according to a statement Thursday. In October, Estée Lauder guided for that figure to be between $1.90 to $2.10.

-Hershey (HSY) shares rise after the chocolate and candymaker offered a better-than-expected 2026 outlook, saying higher prices and new products would bolster the performance. The Pennsylvania-based maker of Hershey’s chocolates and Reese’s Peanut Butter Cups sees adjusted earnings per share of $8.20 to $8.52. The low-end of that range topped Wall Street estimates by about 15%.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Alphabet (GOOGL) falls after the Google parent forecast full year 2026 capital expenditures of up to $185 billion, far exceeding consensus estimates. Analysts said the jump in spending may concern some investors, while others said it underscored the company’s confidence with AI.

- Qualcomm (QCOM) shares drop. Qualcomm gave a lackluster revenue forecast for the current period, citing concern that component shortages will hurt consumer demand by driving prices up.

- Novo Nordisk (NVO) shares fall. This came after a report that Hims & Hers Health Inc. will begin offering a version of its new weight loss pill at a lower price. The telehealth firm will offer a copycat version of the drug starting at $49 a month through a subscription program.
See omnystudio.com/listener for privacy information.